Amount of Lactose Causing Symptoms in Lactose Intolerant People

This study has been completed.

Sponsor:

Information provided by:

University Hospitals, Leicester

ClinicalTrials.gov Identifier:

NCT00395954

First received: November 2, 2006

Last updated: February 13, 2009

Last verified: February 2009

History of Changes

Purpose

The hypothesis underlying this study is that failure to recognise the role of lactose intolerance among patients has led to inappropriate dietary advice and treatment with drugs that contain lactose as a filler. These failures exacerbate symptoms and lead to the unnecessary use of immune suppressant drugs.

This study will identify the threshold at which symptoms of lactose intolerance develop, to provide appropriate advice and treatment in the management of patients.

Condition	Phase
Lactose Intolerance	Early Phase 1


Study Type:	Observational
Study Design:	Time Perspective: Prospective
Official Title:	A Study to Determine the Threshold of Lactose Ingestion That Provokes Symptoms in Lactose Intolerant People.

Resource links provided by NLM:

Genetics Home Reference related topics: lactose intolerance

MedlinePlus related topics: Lactose Intolerance

U.S. FDA Resources

Further study details as provided by University Hospitals, Leicester:


Estimated Enrollment:	48
Study Start Date:	November 2006
Study Completion Date:	June 2007
Primary Completion Date:	June 2007 (Final data collection date for primary outcome measure)

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Confirmed lactose intolerance demonstrated with a lactose intolerance test.
Adherence to a lactose free diet for at least four days before the start of the study.

Exclusion Criteria:

Failure to adhere to a lactose free diet.
People who are on lactose containing medications.
Pregnancy.
Unwillingness to comply with study outline.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00395954

Sponsors and Collaborators

University Hospitals, Leicester

Investigators


Principal Investigator:	John F Mayberry, DSc MD	University Hospitals, Leicester

More Information


Responsible Party:	Carolyn Burden, University Hospitals of Leicester NHS Trust
ClinicalTrials.gov Identifier:	NCT00395954 History of Changes
Other Study ID Numbers:	UHL 10217
Study First Received:	November 2, 2006
Last Updated:	February 13, 2009

Keywords provided by University Hospitals, Leicester:


Lactose Intolerance Lactose Threshold

Additional relevant MeSH terms:


Lactose Intolerance Malabsorption Syndromes Intestinal Diseases Gastrointestinal Diseases Digestive System Diseases	Carbohydrate Metabolism, Inborn Errors Metabolism, Inborn Errors Genetic Diseases, Inborn Metabolic Diseases

ClinicalTrials.gov processed this record on August 18, 2017

To Top